Moderna, Inc. (0QF.F)

EUR 24.0

(-2.24%)

Net Debt Summary of Moderna, Inc.

  • Moderna, Inc.'s latest annual net debt in 2023 was -1.66 Billion USD , up 17.01% from previous year.
  • Moderna, Inc.'s latest quarterly net debt in 2024 Q2 was -1.2 Billion USD , down -48.53% from previous quarter.
  • Moderna, Inc. reported annual net debt of -2 Billion USD in 2022, up 66.2% from previous year.
  • Moderna, Inc. reported annual net debt of -5.93 Billion USD in 2021, down -145.47% from previous year.
  • Moderna, Inc. reported quarterly net debt of -1.2 Billion USD for 2024 Q2, down -48.53% from previous quarter.
  • Moderna, Inc. reported quarterly net debt of -2.51 Billion USD for 2023 Q1, down -25.39% from previous quarter.

Annual Net Debt Chart of Moderna, Inc. (2023 - 2016)

Historical Annual Net Debt of Moderna, Inc. (2023 - 2016)

Year Net Debt Net Debt Growth
2023 -1.66 Billion USD 17.01%
2022 -2 Billion USD 66.2%
2021 -5.93 Billion USD -145.47%
2020 -2.41 Billion USD -2234.57%
2019 -103.51 Million USD 83.43%
2018 -624.87 Million USD -424.35%
2017 -119.17 Million USD -217.12%
2016 -37.58 Million USD 0.0%

Peer Net Debt Comparison of Moderna, Inc.

Name Net Debt Net Debt Difference
BioNTech SE -11.44 Billion EUR 85.46%
CureVac N.V. -360.92 Million EUR -361.037%
Biotest Aktiengesellschaft 571.3 Million EUR 391.266%
Biotest Aktiengesellschaft 571.3 Million EUR 391.266%
BRAIN Biotech AG -693 Thousand EUR -240015.44%
Formycon AG 2.45 Million EUR 67990.657%
Heidelberg Pharma AG -37.6 Million EUR -4324.644%
Medigene AG -5.72 Million EUR -28970.58%